Code | 9379B | ||||||||||
MA number | 44/0266/16-S | ||||||||||
Product Form: | imp sip 1x10,8 mg (aplik.inj.ihl.+implantát) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Zentiva k.s., Czechia | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Container: | needle applicator | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
Pediatric warnings: | Yes |
SPC: | SPC_Reseligo 10,8 mg_01/2021.doc |
PIL: | PIL_Reseligo 10,8 mg_01/2021.doc |
Safety feature | Yes |
Data update: | 26.04.2023 |